Profund Advisors LLC Repligen Corp Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Repligen Corp stock. As of the latest transaction made, Profund Advisors LLC holds 1,504 shares of RGEN stock, worth $217,267. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,504

Holding current value

$217,267

% of portfolio

0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.79 - $167.35 $180,164 - $251,694	1,504 New	1,504 $223,000
Q1 2024 May 08, 2024	BUY	$170.78 - $208.42 $63,188 - $77,115	370 Added 21.96%	2,055 $377,000
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $32,766 - $53,195	287 Added 20.53%	1,685 $302,000
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $31,503 - $40,067	-227 Reduced 13.97%	1,398 $222,000
Q2 2023 Aug 10, 2023	SELL	$138.42 - $180.31 $20,347 - $26,505	-147 Reduced 8.3%	1,625 $229,000
Q1 2023 May 11, 2023	SELL	$154.26 - $198.1 $877,430 - $1.13 Million	-5,688 Reduced 76.25%	1,772 $298,000
Q4 2022 Feb 02, 2023	BUY	$162.42 - $220.56 $20,789 - $28,231	128 Added 1.75%	7,460 $1.26 Million
Q3 2022 Nov 04, 2022	SELL	$160.42 - $256.21 $43,152 - $68,920	-269 Reduced 3.54%	7,332 $1.37 Million
Q2 2022 Aug 01, 2022	SELL	$140.68 - $188.02 $118,311 - $158,124	-841 Reduced 9.96%	7,601 $1.23 Million
Q1 2022 May 10, 2022	SELL	$161.19 - $257.96 $147,811 - $236,549	-917 Reduced 9.8%	8,442 $1.59 Million
Q4 2021 Feb 08, 2022	SELL	$247.59 - $304.47 $345,883 - $425,344	-1,397 Reduced 12.99%	9,359 $2.48 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $128,937 - $214,627	-662 Reduced 5.8%	10,756 $3.11 Million
Q2 2021 Aug 12, 2021	SELL	$165.87 - $220.95 $49,263 - $65,622	-297 Reduced 2.54%	11,418 $2.28 Million
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $422,246 - $529,674	-2,341 Reduced 16.65%	11,715 $2.28 Million
Q4 2020 Feb 09, 2021	BUY	$148.08 - $206.57 $208,792 - $291,263	1,410 Added 11.15%	14,056 $2.69 Million
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $30,504 - $39,409	249 Added 2.01%	12,646 $1.87 Million
Q2 2020 Aug 03, 2020	BUY	$94.33 - $140.48 $115,742 - $172,368	1,227 Added 10.98%	12,397 $1.53 Million
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $458,019 - $588,373	-5,391 Reduced 32.55%	11,170 $1.08 Million
Q4 2019 Feb 18, 2020	BUY	$73.84 - $93.08 $124,789 - $157,305	1,690 Added 11.36%	16,561 $1.53 Million
Q3 2019 Nov 12, 2019	BUY	$76.65 - $95.51 $816,552 - $1.02 Million	10,653 Added 252.56%	14,871 $1.14 Million
Q2 2019 Aug 13, 2019	BUY	$54.2 - $85.95 $596 - $945	11 Added 0.26%	4,218 $363,000
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $75,806 - $96,272	-1,533 Reduced 26.71%	4,207 $249,000
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $101,635 - $145,061	-2,106 Reduced 26.84%	5,740 $303,000
Q3 2018 Nov 13, 2018	SELL	$46.8 - $58.97 $19,141 - $24,118	-409 Reduced 4.95%	7,846 $435,000
Q2 2018 Aug 13, 2018	BUY	$35.26 - $47.04 $38,116 - $50,850	1,081 Added 15.07%	8,255 $388,000
Q1 2018 May 14, 2018	BUY	$30.92 - $37.27 $50,090 - $60,377	1,620 Added 29.17%	7,174 $260,000
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $180,671 - $216,161	5,554 New	5,554 $201,000
Q3 2017 Nov 13, 2017	SELL	$36.98 - $46.06 $235,377 - $293,171	-6,365 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	6,365	6,365 $264,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.09 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$923 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$729 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$235 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$205 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account